Toth Financial Advisory’s Ascendis Pharma A/S ASND Stock Holding History

Toth Financial Advisory’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Buy	5,880 +430	+8%	+$100K	0.15%	121
2026 Q1	$1.25M	Buy	5,450 +810	+17%	+$182K	0.14%	122
2025 Q4	$989K	Buy	4,640 +4,045	+680%	+$835K	0.11%	134
2025 Q3	$118K	Buy	595 +150	+34%	+$28K	0.01%	252
2025 Q2	$76.8K	Sell	445 -4,890	-92%	-$797K	0.01%	269
2025 Q1	$832K	Buy	+5,335	New	+$762K	0.1%	135

Other funds holding ASND

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Bank of New Hampshire Laconia, New Hampshire $479M AUM 31.52% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return